Haley V. Hieronymus, Ph.D.
Affiliations: | 2005 | Harvard University, Cambridge, MA, United States |
Area:
Intracellular CompartmentationGoogle:
"Haley Hieronymus"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mao N, Gao D, Hu W, et al. (2020) Oncogenic ERG represses PI3K signaling through down-regulation of IRS2. Cancer Research |
| Mao N, Gao D, Hu W, et al. (2019) Aberrant expression of ERG promotes resistance to combined PI3K and AR pathway inhibition through maintenance of AR target genes. Molecular Cancer Therapeutics |
| Hieronymus H, Murali R, Tin A, et al. (2018) Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. Elife. 7 |
| Hieronymus H, Murali R, Tin A, et al. (2018) Author response: Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death Elife |
| Kaittanis C, Andreou C, Hieronymus H, et al. (2017) Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. The Journal of Experimental Medicine |
| Kaittanis C, Andreou C, Hieronymus H, et al. (2017) Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. The Journal of Experimental Medicine |
| Hieronymus H, Iaquinta PJ, Wongvipat J, et al. (2017) Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis. Nature Communications. 8: 1081 |
| Hieronymus H, Iaquinta PJ, Wongvipat J, et al. (2017) Abstract 1537: 3p13-14FOXP1-SHQ1deletion spanning multiple potential tumor suppressor genes cooperates withPTENloss in cancer Cancer Research. 77: 1537-1537 |
| Liu X, Grogan TR, Hieronymus H, et al. (2016) Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome. Cell Reports. 17: 2596-2606 |
| Bose R, Abida W, Iaquinta P, et al. (2016) Investigation of a frequently mutated transcriptional repressor in prostate cancer, in particular its role in modulating androgen signaling and its effects on TMPRSS2-ERG dependent tumor maintenance. Journal of Clinical Oncology. 34: 274-274 |